Delivery Order SPE2DB25D3404-SPE2DB25FUNJF
Award Date
5/9/25
Potential Completion Date
5/12/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,290.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Linezolid 600 mg tablets, a prescription medication, and has an ultimate completion date of April 30, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,034.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,560,799,928 tablets of the antibiotic Linezolid 600 mg. The contract is a delivery order that runs through May 3, 2023, with a firm fixed price. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Linezolid 100 mg/5 ml suspension, a pharmaceutical product. The $1,711.91 firm-fixed-price delivery order contract has a completion date of June 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This federal contract award, valued at $3,525.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a Delivery Order to provide LINEZOLID 600 MG TABLET 20S, a pharmaceutical product, with a completion date of December 31, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, valued at $4,816.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of 4567557619 - LINEZOLID 600 MG TABLET 20S, with a period of performance running through March 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 600 mg Linezolid tablets. The contract has a ceiling value of $1,507.56 and a period of performance ending on April 23, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,838.53 firm fixed-price delivery order contract has an ultimate completion date of April 22, 2025. The contract is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,400.96 Firm Fixed Price delivery order contract is for the supply of the medication LINZESS 145 MCG CAPSULE UU 30S. The contract has an ultimate completion date of May 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $13,353.60 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 24, 2024 and is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,451.78 fixed-price delivery order is for the supply of LINZESS 290 MCG capsules to support military healthcare programs. The contract has an ultimate completion date of March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...